44
Views
0
CrossRef citations to date
0
Altmetric
Original Article

The review of results of foetal fibronectin at the Royal Cornwall Hospital Treliske

&

References

  • Abbott D, Radford S, Seed P, Tribe R, Shennan A. 2013. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. American Journal of Obstetrics and Gynaecology 208:122 e1–122 e6.
  • Beck S, Wojdyla D, Say L, Pilar Bertran A, Meraldi M, Harris Requejo J, et al. 2010. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization 88:31–38.
  • Bolt L, Chandiramani M, De Greeff A, Seed P, Shennan A. 2009. Does fetal fibronectin testing change patient management in women at risk of preterm labour? European Journal of Obstetrics and Gynaecology and Reproductive Biology 146:180–183.
  • Boots A, Sanchez-Ramos L, Bowers D, Kaunitz A, Zamora J, Schlattmann P. 2014. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. American Journal of Obstetrics and Gynecology 210:54 e1–54 e10.
  • Ferguson J, Dyson D, Schutz T, Stevenson D. 1990. A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome. American Journal of Obstetrics and Gynecology 163:105–111.
  • Giles W, Bisits A, Knox M, Madsen G, Smith R. 2000. The effect of fetal fibronectin testing on admissions to a tertiary maternal–fetal medicine unit and cost savings. American Journal of Obstetrics and Gynaecology 182:439–442.
  • Goffinet F. 2005. Primary predictors of preterm labour. BJOG: An International Journal of Obstetrics & Gynaecology 112:38–47.
  • Goldenberg R, Iams J, Mercer B, Meis P, Moawad A, Copper R, et al. 1998. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. American Journal of Public Health 88:233–238.
  • Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379:2151–2161.
  • Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, et al. 1991. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. New England Journal of Medicine 325:669–674.
  • MacDonald WA, Bender M, Saxton A. 2007. Use of fetal fibronectin in the management of preterm labour in Nunavut. Alaska Medicine 49:215–217.
  • Malak T, Sizmur F, Bell S, Taylor D. 1996. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth. British Journal of Obstetrics and Gynaecology 103:648–653.
  • Mercer B, Goldenberg R, Moawad A, Meis P, Iams J, Das A, et al. 1999. The Preterm Prediction Study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. American Journal of Obstetrics and Gynecology 181: 1216–1221.
  • Merkatz R. 1978. Prolonged hospitalization of pregnant women: the effects on the family. Birth 5:204–206.
  • Petrou S. 2005. The economic consequences of preterm birth during the first 10 years of life. BJOG: An International Journal of Obstetrics and Gynaecology 112:10–15.
  • Rizzo G, Capponi A, Arduini D, Lorido C, Romanini C. 1996. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. American Journal of Obstetrics and Gynecology 175:1146–1151.
  • Skoll A, St. Louis P, Amiri N, Delisle M, Lalji S. 2006. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients. Journal of Obstetrics and Gynecology Canada 28:206–213.
  • Steer P. 2005. The epidemiology of preterm labour. BJOG: An International Journal of Obstetrics and Gynecology 112:1–3.
  • WHO. 1976. Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstetricia et Gynecologica Scandinavica 56:247–253.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.